South Korea to India: Diagnostic Import Trade Route

The South Korea to India Diagnostic corridor is one of India's established pharmaceutical import routes from South Korea, with 453 shipments documented worth a combined $1.2M USD. The route is dominated by BODITECH MED INC, which alone accounts for roughly 85% of all import value, reflecting the consolidated nature of South Korea's diagnostic export sector.

Across 3 active South Korea suppliers, the average shipment value stands at $2.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with diagnostic's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 17.5%, placing it at rank #2 among India's top diagnostic import origins globally.

On the Indian buyer side, key Indian importers include CPC DIAGNOSTICS PRIVATE LIMITED, CPC DIAGNOSTICS PRIVATE LTD, BODITECH MED INDIA PRIVATE LIMITED and 9 others. CPC DIAGNOSTICS PRIVATE LIMITED is the single largest Indian importer with 69 shipments valued at $438.5K USD.

India's diagnostic imports from South Korea are driven primarily by a handful of large-scale South Korea manufacturers. BODITECH MED INC with 324 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — Indian buyers benefit from South Korea supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BODITECH MED INC, BODITECH MED INC., MEDIAN DIAGNOSTICS INC — together account for 100% of total trade value on this route. The average shipment value of $2.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as cfpc 22 i chroma tsh diagnostics test kit 1000 box and cfpc-137 i chroma hba1c neo diagnostics test kit 2000 box, suggesting that Indian buyers tend to consolidate orders across related product lines from the same South Korea supplier.

On the buying side, CPC DIAGNOSTICS PRIVATE LIMITED is the largest importer with 69 shipments worth $438.5K USD — representing 35% of all diagnostic imports from South Korea on this route. A total of 12 buyers are active on this corridor.